| Name | (R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide |
|---|
| Description | (R)-Larotrectinib is a potent TRK inhibitor with an IC50 value of 28.5 nM for TrkA. (R)-Larotrectinib can be used for researching cancer, inflammatory and certain infectious diseases[1] |
|---|---|
| Related Catalog | |
| Target |
TrkA:28.5 nM (IC50) |
| References |
| Molecular Formula | C21H22F2N6O2 |
|---|---|
| Molecular Weight | 428.44 |